Jt Stratford LLC Infinity Pharmaceuticals, Inc. Transaction History

Jt Stratford LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $8,575 - $21,000	-17,500 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.85 - $2.4 $14,875 - $42,000	17,500 New	17,500 $20,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Jt Stratford LLC, based on Form 13F filings with the SEC.

Stay updated on Jt Stratford LLC with notifications on news.